- CitiesIncreased training capacity and faculty development could expand the number of clinicians and educators with palliative…
- CommunitiesTargeted grant priorities for rural, medically underserved, pediatric, and racial/ethnic minority populations could imp…
- Federal agenciesFederal funding and NIH research strategy may accelerate evidence generation and dissemination about palliative care be…
Palliative Care and Hospice Education and Training Act
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
The bill creates a new, permanent palliative care and hospice education and training program within the Public Health Service Act to expand workforce capacity, faculty careers, fellowships, and interprofessional training across medicine, nursing, social work, physician assistant, chaplaincy, pharmacy, psychology, and related programs. It authorizes grant and contract awards for clinical training, community-based programs, faculty development, retraining of physicians, short intensive fellowships for faculty, career incentive awards with service obligations, and targeted priorities for rural, underserved, pediatric, and racial/ethnic minority populations.
Scale and scope of federal spending: liberals view funding as necessary and beneficial; conservatives worry about new federal expenditures and recurring obligations.
Relative to its intended legislative type, this bill is a substantive statutory package that establishes new grant and award authorities, funding authorizations, NIH research strategy obligations, and information-dissemination responsibilities tied to palliative care and hospice education and workforce development.
The bill creates a new, permanent palliative care and hospice education and training program within the Public Health Service Act to expand workforce capacity, faculty careers, fellowships, and interprofessional training across medicine, nursing, social work, physician assistant, chaplaincy, pharmacy, psychology, and related programs.
It authorizes grant and contract awards for clinical training, community-based programs, faculty development, retraining of physicians, short intensive fellowships for faculty, career incentive awards with service obligations, and targeted priorities for rural, underserved, pediatric, and racial/ethnic minority populations.
The measure also directs federal dissemination of information about palliative care benefits and requires the NIH to develop a cross‑institute research strategy for palliative care; it includes a prohibition on using funds to provide or promote services for which federal funding is unavailable and states that palliative care shall not be used to cause or assist in causing a patient’s death.
By content alone, the bill is narrowly focused on workforce training, research, and information dissemination in a low‑controversy area, with modest authorized funding and compromise elements that historically attract bipartisan support. The principal obstacles are procedural (competing legislative priorities, requirement for appropriations, and securing floor time in both chambers), not policy controversy.
Relative to its intended legislative type, this bill is a substantive statutory package that establishes new grant and award authorities, funding authorizations, NIH research strategy obligations, and information-dissemination responsibilities tied to palliative care and hospice education and workforce development. It integrates cleanly into the Public Health Service Act and provides moderate operational detail while leaving customary administrative choices to the Secretary.
Scale and scope of federal spending: liberals view funding as necessary and beneficial; conservatives worry about new federal expenditures and recurring obligations.
Who stands to gain, and who may push back.
These are examples from the analysis, not a ranked list of the most-affected groups.
- Federal agenciesThe bill authorizes new federal spending (explicitly $15 million/year for one program and $5 million/year for nursing p…
- Potential burdenAdministrative and compliance burdens on medical, nursing, and allied programs to apply for, manage, and report on mult…
- Potential burdenGiven the scale of the authorized funding relative to national workforce shortages, critics may argue the program is un…
Why the argument around this bill splits.
Scale and scope of federal spending: liberals view funding as necessary and beneficial; conservatives worry about new federal expenditures and recurring obligations.
This persona is likely to view the bill positively as a targeted federal investment to expand access to quality palliative and hospice care, strengthen interdisciplinary training, and support diversity and equity priorities (rural, pediatric, and racial/ethnic minority populations).
They will welcome faculty career awards and incentives that build a sustainable academic workforce and the NIH strategy to expand palliative care research.
They may consider the authorized funding modest relative to need and want stronger guarantees that programs reach underserved communities and that funds promote equitable access.
A pragmatic centrist will generally support the bill’s aims—building workforce capacity, encouraging interprofessional training, and expanding research—while seeking assurances about cost-effectiveness, oversight, and nonduplication with existing programs.
They will note the bill includes prioritization and maintenance-of-effort language, caps on award amounts, and some performance expectations, but will want clearer metrics, reporting requirements, and evaluation of outcomes.
They will view the NIH research strategy and public dissemination as sensible complements but expect careful implementation to avoid waste or overlapping federal efforts.
A mainstream conservative will be cautious about expanding federal grant programs into medical education and workforce development, expressing concerns about increased federal spending, new bureaucracy, and long-term obligations for appropriations.
They may accept the general goal of better palliative care training but prefer state, private, or philanthropic solutions and tighter limits on federal involvement.
The explicit prohibition on using funds to cause or assist in causing a patient’s death will be reassuring on end-of-life controversy, but questions about ongoing cost, federal micromanagement of curricula, and potential mission creep will weigh against strong support.
The path through Congress.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
By content alone, the bill is narrowly focused on workforce training, research, and information dissemination in a low‑controversy area, with modest authorized funding and compromise elements that historically attract bipartisan support. The principal obstacles are procedural (competing legislative priorities, requirement for appropriations, and securing floor time in both chambers), not policy controversy.
- Whether and when Congress will provide the authorized appropriations — authorization does not guarantee funding; actual implementation depends on appropriations decisions.
- No CBO cost estimate is included in the bill text provided; other budgetary offsets or administrative resource needs (e.g., for NIH coordination) are not specified.
Recent votes on the bill.
No vote history yet
The bill has not accumulated any surfaced votes yet.
Go deeper than the headline read.
Scale and scope of federal spending: liberals view funding as necessary and beneficial; conservatives worry about new federal expenditures…
By content alone, the bill is narrowly focused on workforce training, research, and information dissemination in a low‑controversy area, wi…
Relative to its intended legislative type, this bill is a substantive statutory package that establishes new grant and award authorities, funding authorizations, NIH research strategy obligations, and information-dissem…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.